BioRestorative Therapies CEO Lance Alstodt's 2021 pay jumps 33,082% to $21M
BioRestorative Therapies reports 2021 executive compensation
By ExecPay News
Published: August 4, 2023
BioRestorative Therapies reported fiscal year 2021 executive compensation information on August 4, 2023.
In 2021, three executives at BioRestorative Therapies received on average a compensation package of $14M, a 10,383% increase compared to previous year.
Average pay of disclosed executives at BioRestorative Therapies
Lance Alstodt, Chief Executive Officer, received $21M in total, which increased by 33,082% compared to 2020. 66% of Alstodt's compensation, or $14M, was in option awards. Alstodt also received $275K in salary and $7M in stock awards.
Francisco Silva, VP, Research and Development, received a compensation package of $21M, which increased by 10175% compared to previous year. 66% of the compensation package, or $14M, was in option awards.
Robert Kristal, Chief Financial Officer, earned $82K in 2021.
Related executives
You may also like
Source: SEC filing on August 4, 2023.